Eli Lilly’s stock saw a significant increase on Wednesday after the U.S. government approved the company’s GLP-1 drug for obesity treatment. The FDA’s decision was no surprise, and now Eli Lilly is gearing up to market the drug as Zepbound. The stock price soared by almost 2% in response to the news, reaching $611.36 per…
Apple (AAPL) stock is on the brink of a surge in value, driven by the long-term growth potential in China and the positive impact of the upcoming release of its mixed-reality headset. According to Bank of America, Apple’s business in China has shown “promising” revenue figures, fueling optimism about future growth. Additionally, the highly anticipated…
Nvidia, the renowned chipmaker and leader in artificial intelligence (AI) technology, continues to receive support from its Big Tech counterparts. Microsoft, Alphabet, Meta Platforms (formerly known as Facebook), and Amazon, all major players in the tech industry, have recently announced their ongoing investments in AI advancements. This is great news for Nvidia, as these companies…
Tech giant faces negative headlines in recent months In what appears to be an ongoing trend, the tech giant has once again found itself at the center of negative publicity. This comes as no surprise, as the company has been no stranger to controversy in recent months. While the details of the current negative headlines…
Major US Banks Report Strong Earnings in Q3 Despite Challenging Environment In a challenging macroeconomic environment and concerns about the health of the banking sector, the largest financial institutions in the US have all reported earnings beats for the third quarter. While some businesses did better than others, their stock prices have not yet reflected…
